Colinz Laboratories share news, announcements and annual reports
BSE: 531210Pharmaceuticals & BiotechnologySmall Cap
Colinz Laboratories ltd. · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Nov 1995
Last close ₹69.25down ₹0.75 (1.07%)
Share price at the BSE close on 30 Oct 2026. Previous close ₹70.00.
30 Oct: open ₹72.39, high ₹72.39, low ₹67.50
52-week range of traded prices to 30 Oct 2026
₹36.11Low, 13 Nov 2025₹87.91High, 30 Jan 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹17 Cr4,457th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 6.27
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹2.76 crore of one-off items, the largest of them in the quarter to Jun 2026.
- 908.58
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.37
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 24.6%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹2.76 crore of one-off items, the largest of them in the quarter to Jun 2026.
- 0.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 1.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.04
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 1,008
Colinz Laboratories results
81 filed, newest first. Page 2 of 2.
May 2016
Jan 2016
Oct 2015
Aug 2015
Jun 2015
Jan 2015
Oct 2014
Jul 2014
31 Jul · Results
May 2014
30 May · Results
Jan 2014
31 Jan · Results
Oct 2013
31 Oct · Results
Jul 2013
31 Jul · Results
May 2013
30 May · Results
Apr 2013
23 Apr · Results
Since the Company would like to publish the audited results for the financial year 2012-13 on or before May 31, 2013, the Company will not ....
Jan 2013
31 Jan · Results
Oct 2012
31 Oct · Results
Jul 2012
31 Jul · Results
May 2012
31 May · Results
Apr 2012
12 Apr · Results
Company would like to publish the audited results for the financial year 2011-12 on or before May 31, 2012, the Company will not publish ....
Jan 2012
31 Jan · Results
Oct 2011
31 Oct · Results
Jul 2011
30 Jul · Results
May 2011
31 May · Results
6 May · Results
Since the Company would like to publish the audited results for the financial year 2010-11 on or before May 31, 2011, the Company will not ....
Jan 2011
29 Jan · Results
Nov 2010
10 Nov · Results
Aug 2010
4 Aug · Results
May 2010
29 May · Results
Apr 2010
23 Apr · Results
Company to publish the audited results for the financial year 2009-10 on or before May 30, 2010, the Company will not publish the un-audited ....
Feb 2010
2 Feb · Results